Projects per year
Personal profile
Biography
Ian Glaspole performs translational and clinical research in interstitial lung diseases, such as idiopathic pulmonary fibrosis. He is the director of the Interstitial Lung Disease Clinic at the Alfred Hospital, Melbourne. He is an adjunct clinical associate professor of medicine at Monash University’s Central Clinical School Campus.
A/Prof Glaspole has maintained a strong research focus since completing his PhD, within which he studied the human cellular immune response to nut allergens. Since then, his research has focused on interstitial lung disease, and has included numerous clinical trials exploring treatments for idiopathic pulmonary fibrosis, along with other clinical and laboratory based research, principally focused on improving the symptoms and quality of life of sufferers of these rare lung diseases.
His research is funded by the NHMRC, and philanthropic and industry sources. He serves on advisory boards and steering committees for clinical trials in idiopathic pulmonary fibrosis (IPF) and other forms of lung fibrosis. He is the co-chair of the Australian IPF Registry, and a steering committee member of the Centre for Research Excellence in Pulmonary Fibrosis.
A/Prof Glaspole is a member of the Thoracic Society of Australia & New Zealand, the Australian Society of Clinical Immunology and Allergy, and the Australian Sleep Association.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Interstitial lung disease
-
A Randomised, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in subjects with Idiopathic Pulmonary Fibrosis (TETON-2)
Glaspole, I. & Symons, K.
27/10/22 → 27/10/24
Project: Research
-
A randomized, double-blind, dose-ranging, placebo-controlled Phase 2a evaluation of the safety, tolerability, and pharmacokinetics of PLN-74809 in participants with idiopathic pulmonary fibrosis (IPF) (INTEGRIS-IPF).
Glaspole, I., Corte, T. J. & Symons, K. M.
23/03/22 → 31/12/24
Project: Research
-
A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
Glaspole, I. & Symons, K. M.
30/08/21 → 31/12/24
Project: Research
-
Lockdown as the mother of invention: disruptive technology in a disrupted time
Holland, A. E. & Glaspole, I., Jan 2023, In: The Lancet Respiratory Medicine. 11, 1, p. 9-11 3 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
1 Citation (Scopus) -
Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia
Tikellis, G., Corte, T. J., Teoh, A. K. Y., Glaspole, I. N., Macansh, S. & Holland, A. E., Jan 2022, In: Respirology. 27, 1, p. 76-84 9 p.Research output: Contribution to journal › Article › Research › peer-review
4 Citations (Scopus) -
Biomarker signatures for progressive idiopathic pulmonary fibrosis
Clynick, B., Corte, T. J., Jo, H. E., Stewart, I., Glaspole, I. N., Grainge, C., Maher, T. M., Navaratnam, V., Hubbard, R., Hopkins, P. M. A., Reynolds, P. N., Chapman, S., Zappala, C., Keir, G. J., Cooper, W. A., Mahar, A. M., Ellis, S., Goh, N. S., De Jong, E., Cha, L., & 6 others , 1 Mar 2022, In: European Respiratory Journal. 59, 3, 12 p., 2101181.Research output: Contribution to journal › Article › Research › peer-review
10 Citations (Scopus) -
Coagulation factor-XII induces interleukin-6 by primary lung fibroblasts: a role in idiopathic pulmonary fibrosis?
Jaffar, J., McMillan, L., Wilson, N., Panousis, C., Hardy, C., Cho, H-J., Symons, K., Glaspole, I., Westall, G. & Wong, M., Feb 2022, In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 322, 2, p. L258-L272 15 p.Research output: Contribution to journal › Article › Research › peer-review
1 Citation (Scopus) -
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography
Walsh, S. L. F., Mackintosh, J. A., Calandriello, L., Silva, M., Sverzellati, N., Larici, A. R., Humphries, S. M., Lynch, D. A., Jo, H. E., Glaspole, I., Grainge, C., Goh, N., Hopkins, P. M. A., Moodley, Y., Reynolds, P. N., Zappala, C., Keir, G., Cooper, W. A., Mahar, A. M., Ellis, S., & 2 others , 1 Oct 2022, In: American Journal of Respiratory and Critical Care Medicine. 206, 7, p. 883-891 9 p.Research output: Contribution to journal › Article › Research › peer-review
5 Citations (Scopus)